A hybrid Bayesian-frequentist predictive design for monitoring multi-stage clinical trials

DOI10.1080/07474946.2019.1648919zbMath1433.62209OpenAlexW2976466351MaRDI QIDQ5197969

Hayet Merabet, Zohra Djeridi

Publication date: 2 October 2019

Published in: Sequential Analysis (Search for Journal in Brave)

Full work available at URL: https://doi.org/10.1080/07474946.2019.1648919

zbMATH Keywords

stopping ruleBayesian predictionstochastic curtailmentinterim monitoringprediction of satisfaction

Mathematics Subject Classification ID

Applications of statistics to biology and medical sciences; meta analysis (62P10) Optimal statistical designs (62K05) Bayesian inference (62F15) Bayesian problems; characterization of Bayes procedures (62C10) Sequential statistical design (62L05) Sequential statistical analysis (62L10)

Cites Work

• Unnamed Item
• Unnamed Item
• Unnamed Item
• Predictive Probability Early Termination Plans For Phase II Clinical Trials
• USE OF PREDICTIVE PROBABILITIES IN PHASE II AND PHASE III CLINICAL TRIALS
• Bayesian prediction for two-stage sequential analysis in clinical trials
• Bayesian Approaches to Randomized Trials
• Practical Bayesian Guidelines for Phase IIB Clinical Trials
• The Bayesian Choice

This page was built for publication: A hybrid Bayesian-frequentist predictive design for monitoring multi-stage clinical trials